Stay updated on Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Sign up to get notified when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.

Latest updates to the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page
- Check2 days agoChange DetectedAdded two MeSH terms—B-cell chronic lymphocytic leukemia and Malignant lymphoma, large B-cell, diffuse—to the Additional Relevant MeSH Terms.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision added: v3.5.0. Revision removed: v3.4.3.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check52 days agoChange DetectedSite maintenance updates include Revision: v3.4.2 and the removal of a prior funding notice (v3.4.1), which do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedA government funding notice about NIH Clinical Center operations was added, including status guidance and a link to opm.gov, and a new revision tag v3.4.1 appears while the previous v3.4.0 tag is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedThe page now includes a glossary display option, a new 'Last Update Submitted that Met QC Criteria' field, and a 'No FEAR Act Data' note, plus an updated revision label to v3.4.0. The previous 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' entries have been removed or replaced.SummaryDifference0.2%

Stay in the know with updates to Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.